Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

IntroductionOvarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and pathophy...

Full description

Saved in:
Bibliographic Details
Main Authors: Dalia Ibrahim, Melanie Grondin, Kristianne Galpin, Sara Asif, Emily Thompson, Sarah Nersesian, John Abou-Hamad, Maryam Echaibi, Galaxia M. Rodriguez, Pauline Navals, Elizabeth Macdonald, Brianna Ryan, David P. Cook, Jeffrey W. Keillor, Barbara C. Vanderhyden
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
ovarian cancer
transglutaminase 2
immune modulation
targeted therapy
metastasis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1639853/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items